trending Market Intelligence /marketintelligence/en/news-insights/trending/8V49RusaZBx3LbbG7eoWgQ2 content esgSubNav
In This List

Autolus files for potential IPO in US

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Autolus files for potential IPO in US

Autolus Ltd. said it submitted a confidential draft registration statement to the U.S. Securities and Exchange Commission for a potential IPO in the U.S.

The U.K.-based biopharmaceutical company is yet to determine the timing and the terms of the IPO.

The developer of chimeric antigen receptor T cell, or CAR-T, therapies for cancer was spun out of University College London in 2014.